生物反治疗对帕金森病中的焦虑和抑郁症的影响:试点研究
Justus Chun-Yu Chen1,2, Tzu-Yun Tseng3, Jong-Ling Fuh1,2,4
1Division of General Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Journal of movement disorders
|July 13, 2025
概括
生物反疗法 (BT) 在降低帕金森病 (PD) 患者的焦虑方面表现有前途. 这项试点研究发现,治疗后的焦虑明显改善,效果持续一个月.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 康复医学 康复医学 康复医学
背景情况:
- 帕金森病 (PD) 经常伴随着焦虑和抑郁,严重影响生活质量.
- 目前在PD中治疗焦虑和抑郁的治疗选择可能有局限性或副作用.
- 像生物反疗法 (BT) 这样的非药物干预措施需要进行研究来管理这些并发症.
研究的目的:
- 评估在帕金森病患者中实施生物反治疗 (BT) 的可行性.
- 评估BT在缓解PD患者焦虑和抑郁症状方面的潜在疗效.
- 确定BT对该人群情绪症状的短期和一个月的随访影响.
主要方法:
- 采用随机的等候名单受控试验设计.
- 纳入了19名被诊断患有帕金森病 (PD) 和并发性焦虑和/或抑郁症的患者.
- 对焦虑和抑郁的评估在基线进行,在治疗后立即进行,并在一个月的随访中进行.
主要成果:
- 所有19名参与者都完成了这项研究,这表明可行性很好.
- 与对照组相比,在BT后观察到抑郁症评分 (哈密尔顿抑郁评分表) 和焦虑评分 (医院焦虑和抑郁量表 - HADS焦虑子量表) 的显著降低.
- 治疗后立即在HADS抑郁症子表中没有显著改善.
- 在一个月的随访期间,BT的抗焦虑作用仍然存在.
- 基线焦虑水平较高的患者表现出更大的改善.
结论:
- 生物反疗法 (BT) 似乎是一种可行且潜在的有效干预措施,用于减少帕金森病 (PD) 患者的焦虑症状.
- 抗焦虑的BT的益处可能会延长到治疗期间之外.
- 建议对更大样本和更严重的PD群体进行进一步的研究,以确认这些初步发现并探索长期结果.
相关概念视频
Parkinson's Disease: Treatment
385
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
385
Parkinson's Disease: Overview
715
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
715
Behavior Therapy
113
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
113
Neural Regulation
40.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.2K
The Placebo Effect
6.3K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.3K
Generalized Anxiety Disorder
208
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
208


